Skip to content

Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial

Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06950762
Enrollment
50
Registered
2025-04-30
Start date
2025-06-10
Completion date
2026-04-13
Last updated
2025-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restoration of Carious Class v Anterior Teeth

Keywords

Giomer based injectable composite

Brief summary

Using bioactive injectable resin composite in anterior class v carious lesions can provide better aesthetic outcome and marginal integrity by releasing multiple ions, including fluoride. This offers better marginal integrity due to presence of S-PRG fillers

Interventions

PROCEDUREGiomer based injectable composite

Giomers utilize surface pre-reacted glass (SPRG) technology, which involves an acid-base reaction between fluorine-containing glass particles and polymer-containing acid when exposed to water. This reaction results in the formation of a glass ionomer phase, which is then dispersed throughout the resin. Furthermore, the S-PRG fillers present in giomer materials enable the continuous release and replenishment of fluoride, offering long-lasting protection against the recurrence of caries

PROCEDUREUniversal injectable resin composite

Conventional injectable resin composite

Sponsors

Future University in Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 20-60 years. 2. Co-operative participants approving to participate in the study. 3. Male or female patients. 4. Medically free participants. 5. Moderate or high caries risk participants.

Exclusion criteria

1. Systemic disease or severe medical complications. 2. Participants with a history of allergy to any component of restorations will be used in the study. 3. Lack of compliance 4. Evidence of severe bruxism, clenching, or temporomandibular joint disorders or bizarre habits

Design outcomes

Primary

MeasureTime frame
Marginal discoloration using FDI criteria12 Month

Contacts

Primary ContactAbdelrhman Ahmed Elhariry, BDS
abdelrhman.elhariry1998@gmail.com+201069630412

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026